Submit a Letter to the Editor for:
Michael D. Levitt, Julie Furne, John Springfield, Fabrizis Suarez, Eugene DeMaster
J Clin Invest. 1999;
104(8):1107
doi:10.1172/JCI7712
Abstract |
Full text
|
PDF
C
olonic bacteria liberate large quantities of the highly toxic gases hydrogen sulfide (H2S) and methanethiol (CH3SH). The colonic mucosa presumably has an efficient means of detoxifying these compounds, which is thought to occur through methylation of H2S to CH3SH and CH3SH to dimethylsulfide (CH3SCH3). We investigated this detoxification pathway by incubating rat cecal mucosal homogenates with gas containing H2S, CH3SH, or CH3SCH3. Neither CH3SH nor CH3SCH3 was produced during H2S catabolism, whereas catabolism of CH3SH liberated H2S but not CH3SCH3. Thus, H2S and CH3SH are not detoxified by methylation to CH3SCH3. Rather, CH3SH is demethylated to H2S, and H2S is converted to nonvolatile metabolites. HPLC analysis of the homogenate showed the metabolite to be primarily thiosulfate. Analysis of cecal venous blood obtained after intracecal instillation of H235S revealed that virtually all absorbed H2S had been oxidized to thiosulfate. The oxidation rate of H2S by colonic mucosa was 10,000 times greater than the reported methylation rate. Conversion to thiosulfate appears to be the mechanism whereby the cecal mucosa protects itself from the injurious effects of H2S and CH3SH, and defects in this detoxification possibly could play a role in colonic diseases such as ulcerative colitis.
Guidelines:
The Editorial Board will only consider letters that we deem relevant and of interest to our readers. We will not post data that have not been subjected to peer review, nor will we post letters that are essentially a reiteration of another letter. All accepted letters will be posted on our website within one week of acceptance. The Editors reserve the right to edit any letter for length, content, and clarity. Authors of all accepted letters will be asked to preview any changes. Authors will be notified by e-mail if their letters were not accepted. As this is a final decision, no appeals will be considered.
Specific requirements: All letters must be 400 words or fewer. You may enter the letter as plain text or HTML, if you wish. The author's name and e-mail address are required, and will be posted with the letter. All possible conflicts of interest must be noted, even if they are not posted. If you wish to include a figure (keep in mind that non-peer-reviewed data will not be posted), please contact the editor directly at editors@the-jci.org.
